Related Experiment Video
Updated: Jul 16, 2026
09:43
Isolation, Culture, and Characterization of Prostate Cancer-Associated Fibroblasts
Published on: August 1, 2025
The IGF axis in prostate cancer
S Monti1, L Proietti-Pannunzi, A Sciarra
1Azienda Ospedaliera Sant'Andrea, UOC di Endocrinologia, Rome, Italy. salvatore.monti@uniroma1.it
Current Pharmaceutical Design
|March 10, 2007
Summary
The Insulin-like Growth Factor (IGF) axis plays a key role in prostate cancer development and growth. Elevated IGF-I levels are linked to increased prostate cancer risk, impacting cell growth and survival.
Area of Science:
- Oncology
- Endocrinology
- Molecular Biology
Background:
- Prostate cancer is a leading cause of male cancer deaths globally.
- The Insulin-like Growth Factor (IGF) axis is implicated in tumorigenesis.
- Epidemiological studies suggest a link between IGF-I and prostate cancer risk.
Purpose of the Study:
- To review evidence supporting the role of the IGF axis in prostate cancer.
- To analyze epidemiological, in vitro, and in vivo studies on IGF and prostate cancer.
- To consolidate findings on IGF axis involvement in prostate cancer progression.
Main Methods:
- Review of epidemiological studies.
- Analysis of in vitro and animal models of prostate cancer.
- Examination of human ex vivo prostate cancer tissue samples.
Main Results:
- Circulating IGF-I levels correlate positively with increased prostate cancer risk.
- IGF-I/IGF-II activation of IGF-IR promotes prostate cell proliferation and inhibits apoptosis.
- Altered expression of IGF axis components is observed in prostate cancer models and tissues.
Conclusions:
- The IGF axis is significantly involved in prostate cancer development and progression.
- Targeting the IGF axis may offer therapeutic strategies for prostate cancer.
- Further research into the IGF axis in prostate cancer is warranted.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
01:19Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...